Document Detail

The promise and peril of mobile health applications for diabetes and endocrinology.
MedLine Citation:
PMID:  23627878     Owner:  NLM     Status:  MEDLINE    
We are in the midst of what some have called a "mobile health revolution". Medical applications ("apps") for mobile phones are proliferating in the marketplace and clinicians are likely encountering patients with questions about the medical value of these apps. We conducted a review of medical apps focused on endocrine disease. We found a higher percentage of relevant apps in our searches of the iPhone app store compared with the Android marketplace. For our diabetes search in the iPhone store, the majority of apps (33%) focused on health tracking (blood sugars, insulin doses, carbohydrates), requiring manual entry of health data. Only two apps directly inputted blood sugars from glucometers attached to the mobile phone. The remainder of diabetes apps were teaching/training apps (22%), food reference databases (8%), social blogs/forums (5%), and physician directed apps (8%). We found a number of insulin dose calculator apps which technically meet criteria for being a medically regulated mobile application, but did not find evidence for FDA-approval despite their availability to consumers. Far fewer apps were focused on other endocrine disease and included medical reference for the field of endocrinology, access to endocrine journals, height predictors, medication trackers, and fertility apps. Although mobile health apps have great potential for improving chronic disease care, they face a number of challenges including lack of evidence of clinical effectiveness, lack of integration with the health care delivery system, the need for formal evaluation and review and organized searching for health apps, and potential threats to safety and privacy.
Donna S Eng; Joyce M Lee
Related Documents :
23963608 - Poor oral health as a chronic, potentially modifiable dementia risk factor: review of t...
20199838 - Development of a deprivation index and its relation to premature mortality due to disea...
24020558 - Best health depression app best health depression app.
11929508 - The limited incorporation of economic analyses in clinical practice guidelines.
23295378 - Health outcomes among women trafficked for sex in the united states: a closer look.
18641088 - Prospective risk-adjusted morbidity and mortality outcome analysis after therapeutic br...
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural; Review     Date:  2013-04-30
Journal Detail:
Title:  Pediatric diabetes     Volume:  14     ISSN:  1399-5448     ISO Abbreviation:  Pediatr Diabetes     Publication Date:  2013 Jun 
Date Detail:
Created Date:  2013-05-28     Completed Date:  2013-12-26     Revised Date:  2014-06-03    
Medline Journal Info:
Nlm Unique ID:  100939345     Medline TA:  Pediatr Diabetes     Country:  Denmark    
Other Details:
Languages:  eng     Pagination:  231-8     Citation Subset:  IM    
Copyright Information:
© 2013 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Blood Glucose Self-Monitoring
Cellular Phone*
Delivery of Health Care
Device Approval* / legislation & jurisprudence
Diabetes Mellitus / therapy*
Software / standards*
United States
United States Food and Drug Administration
Grant Support
5 T32 DK071212-07/DK/NIDDK NIH HHS; K08 DK082386/DK/NIDDK NIH HHS; K08 DK082386/DK/NIDDK NIH HHS

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Probing active cocaine vaccination performance through catalytic and noncatalytic hapten design.
Next Document:  The Effects of Cannabis Use Expectancies on Self-Initiated Cannabis Cessation.